PLSE — Pulse Biosciences Share News
0.000.00%
Last trade - 00:00- $3.25bn
- $3.15bn
- $0.35m
Brief: Pulse Biosciences Inc Says, On November 30, 2022, Sandra Gardiner, CFO Of Co Gave Notice That She Was Resigning From The Company - Filing
Pulse Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Pulse Biosciences Reports Third Quarter 2022 Financial Results
Pulse Biosciences Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Pulse Biosciences Announces Positive Clinical Data On Nano-Pulse Stimulation Procedure For Low-Risk Basal Cell Carcinoma Lesions
U.S. STOCKS ON THE MOVE-Digital World Acquisition, Carnival, Crypto stocks
U.S. STOCKS ON THE MOVE-Arcutis Biotherapeutics, Chegg, Li Auto
Pulse Bio up as FDA clears device to treat skin disease sebaceous hyperplasia
Brief: Pulse Biosciences Announces FDA 510(K) Clearance For The Treatment Of Sebaceous Hyperplasia
Pulse Biosciences surges after naming new CEO, cutting jobs
Brief: Pulse Biosciences Announces Strategic Change Of Focus In Support Of Additional Opportunities For Medicinal Related Nano-Pulse Stimulation
Brief: Pulse Biosciences Reports Second Quarter 2022 Financial Results
Pulse Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Pulse Biosciences Inc expected to post a loss of 40 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-U.S. homebuilders, AMC Entertainment
U.S. STOCKS ON THE MOVE-Nikola, Coinbase, BridgeBio
Pulse Biosciences up as FDA approves expanded settings for skin device
Brief: Pulse Biosciences Receives FDA 510(K) Clearance Of Expanded Energy Settings For Use With The CellFX System
Brief: Pulse Biosciences, Inc. Announces Changes To Its Rights Offering